Lost in Translation: Bridging the Gap Between Non-Dilutive Funders and Investors in new Therapeutic, Medical Device and Diagnostic Tool Development [April 7, 2026]

Log in to view event links.

As funders of early-stage medical research, HRA member organizations play a pivotal role in moving promising science from the lab toward real-world impact. A journey that everyone agrees takes too long and costs too much. This webinar is designed to help close one underappreciated gap in that process: the difference in how non-dilutive funders i.e. NIH and philanthropic grant-making organizations and dilutive investors such as angels and venture capitalists understand and use the same language.

Terms like milestones, progress, pivot, timeline and success may sound universal, but they carry very different meanings and expectations depending on who is at the table. By bridging this understanding gap, we can set clearer expectations with our grantees, design more effective funding strategies, and ultimately deploy our resources in ways that move more promising therapies from discovery to the point where larger investors are ready to step in and take them forward.